Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 15, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2022. Go to the latest filing (Q3 2026)

21.8B USDQ2 2022
Total value of stock positions
21.8B USD
Positions
81
Share of the ten largest
35.5%

The ten largest positions Q2 2022

  1. T-Mobile US 5.7%▼ −31.7%
  2. Amazon 4.0%▼ −4.2%
  3. Microsoft 3.5%▼ −10.7%
  4. Parker Hannifin 3.5%▼ −3.0%
  5. Chubb Limited 3.4%▲ +17.9%
  6. Mastercard 3.3%▲ +28.4%
  7. Elevance Health 3.2%▲ +939.4%
  8. Centene Corporation 3.2%▲ +6.2%
  9. Fortive 2.9%▼ −1.9%
  10. International Flavors & Fragrances 2.8%▲ +34.9%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2022

Positions Q2 2022 per 13F filing, 33 of 33
Symbol Weight Shares Reported value Change Held since
Catalent Inc 1.0% 1,961,249 210.4M USD +3.6% increased Q1 2018 18 quarters
CNC Centene Corporation 3.2% 8,293,867 701.7M USD +6.2% increased Q2 2018 17 quarters
BSX Boston Scientific 2.5% 14,653,954 546.2M USD +14.1% increased Q3 2018 16 quarters
Avantor Inc 0.9% 6,168,685 191.8M USD +78.3% increased Q2 2019 13 quarters
Molina Healthcare Inc 0.6% 475,158 132.9M USD +14.0% increased Q3 2019 12 quarters
CB Chubb Limited 3.4% 3,774,226 741.9M USD +17.9% increased Q1 2020 10 quarters
Royalty Pharma PLC 2.4% 12,370,694 520.1M USD +14.9% increased Q2 2020 9 quarters
Api Group Corp 2.3% 33,634,813 503.5M USD +0.5% increased Q2 2020 9 quarters
TMO Thermo Fisher Scientific 2.2% 862,587 468.6M USD +78.0% increased Q2 2020 9 quarters
Karuna Therapeutics Inc 0.6% 1,119,360 141.6M USD +14.9% increased Q3 2020 8 quarters
META Meta Platforms 2.1% 2,865,864 462.1M USD +136.9% increased Q4 2020 7 quarters
MRSH Marsh McLennan 2.0% 2,828,603 439.1M USD +25.7% increased Q4 2020 7 quarters
Acadia Healthcare Company In 1.1% 3,478,476 235.2M USD +63.3% increased Q4 2020 7 quarters
AMP Ameriprise Financial 1.3% 1,183,896 281.4M USD +28.2% increased Q1 2021 6 quarters
CRL Charles River Laboratories 0.5% 553,409 118.4M USD +6.1% increased Q1 2021 6 quarters
Zai Lab Ltd 0.5% 3,299,598 114.4M USD +5.3% increased Q1 2021 6 quarters
Pharvaris N V 0.3% 2,491,923 55.1M USD +0.5% increased Q1 2021 6 quarters
BKNG Booking Holdings 0.7% 89,251 156.1M USD +64.6% increased Q2 2021 5 quarters
Day One Biopharmaceuticals I 0.2% 1,857,424 33.2M USD +60.5% increased Q2 2021 5 quarters
Hdfc Bank Ltd 2.3% 9,182,277 504.7M USD +29.8% increased Q3 2021 4 quarters
UBER Uber 1.6% 16,583,623 339.3M USD +58.9% increased Q3 2021 4 quarters
Celldex Therapeutics Inc New 0.3% 2,337,854 63.0M USD +26.6% increased Q3 2021 4 quarters
IFF International Flavors & Fragrances 2.8% 5,121,603 610.1M USD +34.9% increased Q4 2021 3 quarters
Biomarin Pharmaceutical Inc 1.9% 5,052,593 418.7M USD +34.6% increased Q4 2021 3 quarters
XYZ Block, Inc. 1.6% 5,603,207 344.4M USD +1,140.9% increased Q4 2021 3 quarters
TTWO Take-Two Interactive 1.1% 1,999,669 245.0M USD +239.8% increased Q4 2021 3 quarters
Lianbio < 0.1% 3,564,173 7.7M USD +137.6% increased Q4 2021 3 quarters
MA Mastercard 3.3% 2,302,305 726.3M USD +28.4% increased Q1 2022 2 quarters
ELV Elevance Health 3.2% 1,464,485 706.7M USD +939.4% increased Q1 2022 2 quarters
DG Dollar General 1.3% 1,110,174 272.5M USD +185.9% increased Q1 2022 2 quarters
BA Boeing 0.9% 1,391,238 190.2M USD +355.6% increased Q1 2022 2 quarters
Unum Group 0.7% 4,310,548 146.6M USD +278.9% increased Q1 2022 2 quarters
Inspire Med Sys Inc 0.5% 595,193 108.7M USD +91.5% increased Q1 2022 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 74.7M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 74.7M USD

Breakdown by sector

  • Financials 18.1%
  • Health Care 14.6%
  • Industrials 11.4%
  • Communication Services 9.7%
  • Technology 8.9%
  • Consumer Discretionary 5.0%
  • Materials 2.8%
  • Consumer Staples 1.3%
  • not in our coverage 28.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close